Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

VRCTC-310-Onco enhances serum antiinflammatory cytokine production in humans

July 28, 2000

New allogeneic cancer vaccines in development at Onyvax

July 25, 2000

Genentech acquires rights to PSCA from UroGenesys

July 21, 2000

M-Vax now available in Australia for melanoma therapy

July 20, 2000

Maxim submits NDA for Maxamine

July 20, 2000

Joint venture for OvaRex initiated by AltaRex in Middle East

July 14, 2000

Antisoma resumes enrollment in SMART phase III trial

July 14, 2000

Chiron reports new durable response data for Proleukin

July 13, 2000

KS Biomedix seeks approval to begin clinical trials of anticancer antibody

July 11, 2000

AltaRex establishes joint venture for OvaRex

July 6, 2000

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...